NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

A renowned virologist and former vice-chancellor of Redeemer’s University, Prof. Oyewale Tomori, has warned that Lassa fever ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

The NCDC on Wednesday, confirmed 563 Lassa fever cases out of the 2,960 suspected cases of the disease and 103 deaths as of ...

Lassa fever remains a major health challenge in Nigeria, killing 100 people in early 2025. What’s going wrong?

The Nigeria Centre for Disease Control and Prevention (NCDC) has recorded 28 new confirmed cases and three deaths from Lassa ...

Renowned Nigerian physician, Dr. Tochi Okwor, said that the 2018 Lassa fever outbreak exposed critical gaps in the nation’s infection ...

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a decline in new confirmed Lassa fever cases across ...

A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun ...